Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-d-glucuronic Acid-5,6-dihydroxy-flavone
2. 7-d-glucuronic Acid-5,6-dihydroxyflavone
1. 21967-41-9
2. Baicalein 7-o-glucuronide
3. 7-d-glucuronic Acid-5,6-dihydroxyflavone
4. Mfcd00134418
5. Chebi:2981
6. Chembl485818
7. 31564-28-0
8. 5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yl Beta-d-glucopyranosiduronic Acid
9. Baicalein 7-o-.beta.-d-glucuronide
10. 347q89u4m5
11. (2s,3s,4s,5r,6s)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic Acid
12. 5,6,7-trihydroxyflavone 7-o-beta-d-glucuronide
13. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic Acid
14. (2s,3s,4s,5r,6s)-6-[(5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic Acid
15. 5,6-dihydroxy-4-oxo-2-phenyl-4h-1-benzopyran-7-yl
16. A-d-glucopyranosiduronic Acid
17. Baicalein 7-glucuronide
18. Baicalein-7-o-glucuronide
19. 5,6-dihydroxy-4-oxo-2-phenyl-4h-1-benzopyran-7-yl Beta-d-glucopyranosiduronic Acid
20. Baikalin
21. Baicaloside
22. Baicalin,(s)
23. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-carboxylic Acid
24. 0xe
25. Baicalin, 95%
26. Baicalin [inci]
27. Baicalin [vandf]
28. Baicalein-7-d-glucuronide
29. Baicalin [who-dd]
30. Schembl285082
31. Baicalein 7-beta-d-glucuronide
32. Baicalein 7-o-b-d-glucuronide
33. Baikal Skullcap Extract Baicalin
34. Unii-347q89u4m5
35. Tjn-151
36. Dtxsid701346569
37. Baicalin, >=99.0% (hplc)
38. Hy-n0197
39. Zinc3943903
40. Bdbm50242173
41. Akos007930529
42. Akos015955933
43. Baicalin 1000 Microg/ml In Methanol
44. Ac-7990
45. Am84780
46. Ccg-214128
47. Cs-5302
48. Beta-d-glucopyranosiduronic Acid, 5,6-dihydroxy-4-oxo-2-phenyl-4h-1-benzopyran-7-yl
49. Baicalein 7-beta-d-glucopyranosiduronate
50. Ncgc00386028-03
51. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4, 5-trihydroxy-oxane-2-carboxylic Acid
52. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-oxane-2-carboxylic Acid
53. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic Acid
54. As-13226
55. Baicalein 7-o-glucuronide [usp-rs]
56. 967b419
57. A815791
58. J-013512
59. Q-100275
60. Q2879368
61. Brd-k49962337-001-01-1
62. Baicalin, European Pharmacopoeia (ep) Reference Standard
63. 5,6,7-trihydroxyflavone-7-o-.beta.-d-glucopyranosideuronic Acid
64. 5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yl Ss-d-glucopyranosiduronic Acid
65. (2s,3s,4s,5r,6r)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic Acid
66. (2s,3s,4s,5r,6s)-6-(5,6-dihydroxy-4-oxo-2-phenyl-4h-chromen-7-yloxy)-3,4,5-trihydroxy-tetrahydro-2h-pyran-2-carboxylic Acid
67. .beta.-d-glucopyranosiduronic Acid, 5,6-dihydroxy-4-oxo-2-phenyl-4h-1-benzopyran-7-yl
| Molecular Weight | 446.4 g/mol |
|---|---|
| Molecular Formula | C21H18O11 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 4 |
| Exact Mass | 446.08491139 g/mol |
| Monoisotopic Mass | 446.08491139 g/mol |
| Topological Polar Surface Area | 183 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 748 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Anti-Asthmatic Agents
Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
37
PharmaCompass offers a list of Baicalin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Baicalin manufacturer or Baicalin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Baicalin manufacturer or Baicalin supplier.
PharmaCompass also assists you with knowing the Baicalin API Price utilized in the formulation of products. Baicalin API Price is not always fixed or binding as the Baicalin Price is obtained through a variety of data sources. The Baicalin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Baicalin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Baicalin, including repackagers and relabelers. The FDA regulates Baicalin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Baicalin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Baicalin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Baicalin supplier is an individual or a company that provides Baicalin active pharmaceutical ingredient (API) or Baicalin finished formulations upon request. The Baicalin suppliers may include Baicalin API manufacturers, exporters, distributors and traders.
click here to find a list of Baicalin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Baicalin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Baicalin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Baicalin GMP manufacturer or Baicalin GMP API supplier for your needs.
A Baicalin CoA (Certificate of Analysis) is a formal document that attests to Baicalin's compliance with Baicalin specifications and serves as a tool for batch-level quality control.
Baicalin CoA mostly includes findings from lab analyses of a specific batch. For each Baicalin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Baicalin may be tested according to a variety of international standards, such as European Pharmacopoeia (Baicalin EP), Baicalin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Baicalin USP).
